Published in
Elsevier, Journal of Hepatology, 6(77), p. 1732-1733, 2022
DOI: 10.1016/j.jhep.2022.08.038
Links
Tools
Reply to: “Response to: A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]”
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 